Early Tumour Shrinkage: A Tool for the Detection of Early Clinical Activity in Metastatic Renal Cell Carcinoma. [electronic resource]
Producer: 20171226Description: 1006-1015 p. digitalISSN:- 1873-7560
- Aged
- Antineoplastic Agents -- therapeutic use
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Axitinib
- Bevacizumab -- administration & dosage
- Bone Neoplasms -- drug therapy
- Carcinoma, Renal Cell -- drug therapy
- Clinical Trials, Phase II as Topic
- Clinical Trials, Phase III as Topic
- Disease-Free Survival
- Humans
- Imidazoles -- therapeutic use
- Indazoles -- therapeutic use
- Indoles -- therapeutic use
- Interferon-alpha -- therapeutic use
- Kidney Neoplasms -- drug therapy
- Liver Neoplasms -- drug therapy
- Lung Neoplasms -- drug therapy
- Male
- Middle Aged
- Neoplasm Metastasis
- Niacinamide -- analogs & derivatives
- Phenylurea Compounds -- therapeutic use
- Prognosis
- Proportional Hazards Models
- Pyrroles -- therapeutic use
- Remission Induction
- Retrospective Studies
- Sirolimus -- administration & dosage
- Sorafenib
- Sunitinib
- Survival Rate
- Treatment Outcome
- Tumor Burden
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.